Trends in antibiotic prescribing in Grampian have been monitored prospectiv
ely for 11 years from 1986 using computerized ward stock lists and laborato
ry data relating to all in-patient and out-patient treatments In all Grampi
an hospitals. The main outcome measures were the number of antibiotics avai
lable for routine and restricted use, annual expenditure and defined daily
doses (DDDs) of high expenditure antimicrobial agents. An antibiotic commit
tee introduced a policy and formulary in the third year of the study which
has had only limited success in controlling prescribing. This report update
s the audit from 1992/3 to 1996/7. During this period 22 new antibiotics we
re considered for inclusion in the hospital formulary. Seventeen, including
seven antiretroviral agents, were incorporated, all for restricted use onl
y. Despite this, expenditure on antibiotics has more than trebled since 198
6/7 and increased 50% since 1992/3, two-thirds of the latter increase being
due to the use of new drugs, namely anti-HIV drugs, lipid amphotericin der
ivatives and teicoplanin. Big increases in the use of co-amoxiclav, acyclov
ir, ciprofloxacin and cefotaxime account for the remainder of the increased
expenditure. There was an overall increase of 16.9% in DDDs between 1992/3
and 96/7 to 424.0 DDDs/1000 patient days (393.4 DDDs for antibacterials).
These findings highlight the current difficulty in controlling prescribing
budgets, the increasing use of antibiotics and the consequent increase of a
ntimicrobial-resistant microorganisms.